Patents by Inventor Justin BROWER

Justin BROWER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20130296226
    Abstract: Embodiments described herein are directed to methods for the treatment and control of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of conditions and sequelae that are associated with these diseases, including atherosclerosis and non-insulin dependent diabetes. In addition, embodiments are directed to methods of treating coronary heart disease and metabolic syndrome. Embodiments are also directed to neurotensin analogs. In embodiments, the neurotensin analogs may be capable of binding to neurotensin receptors and, upon binding, may modulate the levels of lipids in subjects.
    Type: Application
    Filed: June 29, 2013
    Publication date: November 7, 2013
    Inventors: Gautam S. GHATNEKAR, Justin BROWER
  • Methods and compositions for the treatment of metabolic disorders
    Patent number: 8476221
    Abstract: Embodiments described herein are directed to methods for the treatment and control of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of conditions and sequelae that are associated with these diseases, including atherosclerosis and non-insulin dependent diabetes. In addition, embodiments are directed to methods of treating coronary heart disease and metabolic syndrome. Embodiments are also directed to neurotensin analogs. In embodiments, the neurotensin analogs may be capable of binding to neurotensin receptors and, upon binding, may modulate the levels of lipids in subjects.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: July 2, 2013
    Assignee: Halimed Pharmaceuticals, Inc.
    Inventors: Gautam S. Ghatnekar, Justin Brower
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20120238490
    Abstract: Embodiments described herein are directed to methods for the treatment and control of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of conditions and sequelae that are associated with these diseases, including atherosclerosis and non-insulin dependent diabetes. In addition, embodiments are directed to methods of treating coronary heart disease and metabolic syndrome. Embodiments are also directed to neurotensin analogs. In embodiments, the neurotensin analogs may be capable of binding to neurotensin receptors and, upon binding, may modulate the levels of lipids in subjects.
    Type: Application
    Filed: March 19, 2012
    Publication date: September 20, 2012
    Inventors: Gautam S. GHATNEKAR, Justin BROWER